PET imaging of proliferation with pyrimidines

OS Tehrani, AF Shields - Journal of Nuclear Medicine, 2013 - Soc Nuclear Med
Several new tracers are being developed for use with PET to assess pathways that are
altered in cancers, including energy use, cellular signaling, transport, and proliferation …

Clinical value of 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer

B Alwadani, S Dall'Angelo, IN Fleming - Insights into Imaging, 2021 - Springer
Lung cancer has the highest mortality rate of any tumour type. The main driver of lung
tumour growth and development is uncontrolled cellular proliferation. Poor patient outcomes …

Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion

A Sarnella, Y Ferrara, L Auletta, S Albanese… - Journal of Experimental …, 2022 - Springer
Background Hypoxic tumor microenvironment (TME) contributes to the onset of many
aspects of the cancer biology associated to the resistance to conventional therapies …

Reversal of warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non–small cell lung cancer

V De Rosa, F Iommelli, M Monti, R Fonti, G Votta… - Clinical Cancer …, 2015 - AACR
Purpose: One of the hallmarks of cancer cells is the excessive conversion of glucose to
lactate under normoxic conditions, also known as the Warburg effect. Here, we tested …

[HTML][HTML] Inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRβ aptamer

S Camorani, BS Hill, R Fontanella, A Greco… - Theranostics, 2017 - ncbi.nlm.nih.gov
Bone marrow-derived mesenchymal stem cells (BM-MSCs) are shown to participate in tumor
progression by establishing a favorable tumor microenvironment (TME) that promote …

[HTML][HTML] Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer

S Camorani, BS Hill, F Collina, S Gargiulo… - Theranostics, 2018 - ncbi.nlm.nih.gov
While the overall mortality for breast cancer has recently declined, management of triple-
negative breast cancer (TNBC) is still challenging because of its aggressive clinical …

Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors

AW Tolcher, P LoRusso, J Arzt, TA Busman… - Cancer chemotherapy …, 2015 - Springer
Abstract Purpose Navitoclax (ABT-263), a novel, oral Bcl-2 inhibitor, enhances the antitumor
effects of chemotherapy in vitro by lowering the apoptotic threshold. This phase I study …

Therapeutic Potential of a Novel αvβ3 Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type

BS Hill, A Sarnella, D Capasso, D Comegna… - Cancers, 2019 - mdpi.com
The mesenchymal sub-type of triple negative breast cancer (MES-TNBC) has a highly
aggressive behavior and worse prognosis, due to its invasive and stem-like features, that …

Autocrine signals increase ovine mesenchymal stem cells migration through Aquaporin‐1 and CXCR4 overexpression

A Pelagalli, A Nardelli, E Lucarelli… - Journal of Cellular …, 2018 - Wiley Online Library
Sheep is a relevant large animal model that is frequently used to test innovative tissue
engineering (TE) approaches especially for bone reconstruction. Mesenchymal stem cells …

Current applications for nuclear medicine imaging in pulmonary disease

JE Kusmirek, JD Magnusson, SB Perlman - Current Pulmonology Reports, 2020 - Springer
Abstract Purpose of Review The main goal of the article is to familiarize the reader with
commonly and uncommonly used nuclear medicine procedures that can significantly …